Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
乌干达残疾人士 MAT 和 NSP 服务中 PrEP 交付和成本计算的实施科学研究
基本信息
- 批准号:10684112
- 负责人:
- 金额:$ 49.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAdherenceAdvocateAfricaAttentionBuprenorphineCapitalCitiesCocaineCommunicable DiseasesCommunitiesConsensusConsolidated Framework for Implementation ResearchConsultationsDataDrug usageDrug userEducational workshopEmpathyEnsureEpidemicEquipmentFundingGuidelinesHIVHIV SeronegativityHarm ReductionHealthHepatitis CHeroinHuman immunodeficiency virus testInjectableInjecting drug userInjectionsInterventionInterviewKnowledgeMeasuresMethodsModelingNeedle-Exchange ProgramsNeedlesOralPersonsPharmaceutical PreparationsPlasmaPolice ForcesPoliciesPopulationPrevalencePreventionPrevention GuidelinesProviderQualitative ResearchReportingResearchRiskScientistService delivery modelService provisionServicesSiteSurveysSyringesTenofovirTransactUgandaUpdateWorkaddictionantiretroviral therapybudget impactcommunity based participatory researchcostcost estimateevidence baseexperiencefollow-upimplementation scienceimprovedinfancymedication-assisted treatmentmembermultidisciplinarynovelpathogenpre-exposure prophylaxispreferenceprescription pain relieverprevention serviceprogramsrecruitscale upsexsocialsocial stigmatraffickingtransmission processtreatment programuptakewillingness
项目摘要
ABSTRACT
In the past decade, Uganda seen increases – as large as 10-fold – in the number of people who use drugs
(PWUD) and the risk for HIV transmission through shared injection equipment, a common practice in this setting
with low access to clean equipment. HIV prevalence among PWUD has been estimated to be as high as
45%, highlighting the importance of widescale access to HIV treatment and prevention for PWUD,
including oral pre-exposure prophylaxis (PrEP). PrEP was integrated into HIV prevention guidelines in
Uganda in 2016 and PEPFAR funding has been supporting targeted rollout to key populations, including PWUD.
However, <250 people currently accessing PrEP have identified as PWUD, indicating a large gap in prevention
and an opportunity to optimize PrEP delivery for PWUD. For PWUD living with HIV, antiretroviral treatment has
been integrated into medication assisted treatment (MAT) programs and needle and syringe exchange programs
(NSP), by leveraging providers who empathize with addiction and have experience combating stigma associated
with drug use. We hypothesize that a similar approach can be done for PrEP by integrating PrEP delivery
into MAT and NSP programs and we proposed a staged approach to conduct formative work and refine
two integrated programs (PrEP + MAT and PrEP + NSP), to pilot these programs and assess PrEP uptake,
retention, and adherence and to conduct costing research to directly inform policy guidance. Our work
will be conducted with attention to several constructs within the Consolidated Framework for Implementation
Research and grounded in a participatory approach with members of the largest harm reduction network, police
force, and PWUD in Uganda as project advisors. Specifically, we aim to: 1) conduct qualitative research to
explore preferences for HIV prevention services and willingness to use/prescribe PrEP among PWUD and
providers of a) oral PrEP and b) services for PWUD in Kampala, Uganda; 2) refine programs for community-
based NSP + PrEP and facility-based MAT + PrEP; 3) compare PrEP uptake, retention, and adherence when
PrEP is integrated into community-based NSP versus facility-based MAT to PWUD; and 4) estimate the
programmatic costs and conduct budget impact analysis for integrating PrEP into our MAT and NSP programs.
Impact. The proposed work will provide robust evidence about how to optimize integrated harm reduction and
PrEP delivery to PWUD in Uganda and similar settings. With direct engagement from members of the Ugandan
Ministry of Health on our investigative team, our findings will be immediately useful for policy guidelines and to
guide programmatic scale-up. This work will be relevant to the US and globally as a demonstration of co-located
harm reduction and HIV prevention services for PWUD and it will provide some of the first data on PrEP
adherence and retention among PWUD.
抽象的
过去十年,乌干达吸毒人数增加了 10 倍
(PWUD) 以及通过共用注射设备传播艾滋病毒的风险,这是这种情况下的常见做法
据估计,残疾人获得清洁设备的机会很少,艾滋病毒感染率高达
45%,强调残疾人士广泛获得艾滋病毒治疗和预防的重要性,
包括口服暴露前预防 (PrEP) 已纳入 HIV 预防指南。
2016 年乌干达和总统防治艾滋病紧急救援计划 (PEPFAR) 提供的资金一直支持对包括残疾人士在内的重点人群进行有针对性的推广。
然而,目前接受 PrEP 的人数不足 250 人,已被确定为 PWUD,这表明预防方面存在巨大差距
对于感染艾滋病毒的残疾人士来说,有机会优化 PrEP 的实施,并提供抗逆转录病毒治疗。
已纳入药物辅助治疗 (MAT) 计划以及针头和注射器交换计划
(NSP),通过利用那些对成瘾问题有同情心并具有抗击相关耻辱经验的提供者
我们努力通过整合 PrEP 递送来对 PrEP 采取类似的方法。
到 MAT 和 NSP 项目中,我们提出了一种分阶段的方法来进行形成性工作和完善
两个综合计划(PrEP + MAT 和 PrEP + NSP),以试点这些计划并评估 PrEP 的采用情况,
保留、遵守并进行成本研究,以直接为政策指导提供信息。
实施时将关注综合实施框架内的若干结构
研究并以最大的减少伤害网络、警察的成员参与的方式为基础
具体来说,我们的目标是:1)进行定性研究
探讨残疾人士和残疾人士对艾滋病毒预防服务的偏好以及使用/开具 PrEP 的意愿
a) 口服 PrEP 和 b) 乌干达坎帕拉残疾人士服务的提供者 2) 完善社区计划;
基于 NSP + PrEP 和基于设施的 MAT + PrEP 3) 比较 PrEP 的吸收、保留和依从性;
PrEP 被纳入基于社区的 NSP 与基于设施的 MAT 到 PWUD;4) 估计
计划成本并进行预算影响分析,将 PrEP 纳入我们的 MAT 和 NSP 计划。
拟议的工作将为如何优化综合伤害减少和影响提供有力的证据。
在乌干达成员的直接参与下,向乌干达 PWUD 提供 PrEP。
卫生部在我们的调查小组中,我们的调查结果将立即用于政策指导和
这项工作将与美国和全球相关,作为同地办公的示范。
为残疾人士提供减少危害和艾滋病毒预防服务,并将提供一些关于 PrEP 的首批数据
PWUD 的依从性和保留率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Renee A. Heffron其他文献
Renee A. Heffron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Renee A. Heffron', 18)}}的其他基金
Effectiveness of PrEP product choice on HIV prevention coverage among young women in Kenya seeking reproductive health services
PrEP 产品选择对寻求生殖健康服务的肯尼亚年轻女性艾滋病毒预防覆盖率的有效性
- 批准号:
10761048 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIVprevention products
指导和研究,为新型 HIV 预防产品准备口服 PrEP 递送平台
- 批准号:
10548809 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
乌干达残疾人士 MAT 和 NSP 服务中 PrEP 交付和成本计算的实施科学研究
- 批准号:
10744381 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
乌干达残疾人士 MAT 和 NSP 服务中 PrEP 交付和成本计算的实施科学研究
- 批准号:
10631694 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIVprevention products
指导和研究,为新型 HIV 预防产品准备口服 PrEP 递送平台
- 批准号:
10642471 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
乌干达残疾人士 MAT 和 NSP 服务中 PrEP 交付和成本计算的实施科学研究
- 批准号:
10631694 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Mentoring and research to prepare oral PrEP delivery platforms for novel HIV prevention products
指导和研究,为新型艾滋病毒预防产品准备口服 PrEP 递送平台
- 批准号:
10322040 - 财政年份:2021
- 资助金额:
$ 49.96万 - 项目类别:
Feasibility pilot of home-based STI testing and risk self-assessment among adolescent girls in South Africa to trigger PrEP re-start
在南非少女中进行家庭性传播感染检测和风险自我评估以触发 PrEP 重新启动的可行性试点
- 批准号:
10678858 - 财政年份:2021
- 资助金额:
$ 49.96万 - 项目类别:
Feasibility pilot of home-based STI testing and risk self-assessment among adolescent girls in South Africa to trigger PrEP re-start
在南非少女中进行家庭性传播感染检测和风险自我评估以触发 PrEP 重新启动的可行性试点
- 批准号:
10256147 - 财政年份:2021
- 资助金额:
$ 49.96万 - 项目类别:
相似国自然基金
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于健康行为程式模型提升高血压患者药物依从性的干预策略构建研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development and pilot testing of a mobile health application to improve HIV prevention and substance use treatment service access among women involved in the carceral system
开发并试点测试移动医疗应用程序,以改善监狱系统中妇女的艾滋病毒预防和药物滥用治疗服务的获取
- 批准号:
10619999 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Effectiveness of PrEP product choice on HIV prevention coverage among young women in Kenya seeking reproductive health services
PrEP 产品选择对寻求生殖健康服务的肯尼亚年轻女性艾滋病毒预防覆盖率的有效性
- 批准号:
10761048 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Implementation science research on PrEP delivery and costing within MAT andNSP services for PWUD in Uganda
乌干达残疾人士 MAT 和 NSP 服务中 PrEP 交付和成本计算的实施科学研究
- 批准号:
10631694 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599557 - 财政年份:2022
- 资助金额:
$ 49.96万 - 项目类别: